Senti Biosciences, Inc. (SNTI)
Senti Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Senti Biosciences, Inc. (SNTI) is a Biotechnology company based in US with a market capitalization of $12.6M. Free cash flow was negative at -$43.6M. This page tracks SNTI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 34 employees · IPO May 26, 2021
Valuation
Valuation & price
$1.01as of May 17, 2026· -57.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.25
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$12.6M
Market cap
—
Revenue growth (YoY)
-16431.8%
Gross margin
-$43.6M
Free cash flow (USD)
$12.5M
Net debt
4791.9%
Share dilution
0/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 14, 2026 (EPS $-0.36)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- FinancingJul 16, 2026Filing
Securities Registration
- 8-K eventJul 15, 2026Filing
Merger Agreement
- FinancingJun 18, 2026Filing
Securities Registration
- 8-K eventMay 26, 2026Filing
Senior Secured Convertible Note Issued
- 8-K eventMay 14, 2026Filing
Earnings Release
- Quarterly reportMay 14, 2026Filing
10-Q Filed
- 8-K eventMay 1, 2026Filing
Convertible Note Issuance
- Annual reportApr 29, 2026Filing
10-K Filed
- 8-K eventApr 1, 2026Filing
Holding Company Reorganization
Questions
Frequently asked questions
What is Senti Biosciences, Inc.'s market cap?
Senti Biosciences, Inc. (SNTI) has a market capitalization of $12.6M.
What is SNTI's P/E ratio?
A meaningful P/E ratio is not available for SNTI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is SNTI's price-to-book (P/B) ratio?
SNTI trades at 2.25 times book value per share.
When did Senti Biosciences, Inc. last report earnings?
SNTI last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying SNTI stock?
SEC Form 4 filings show no open-market insider buys at Senti Biosciences, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.